Cargando…

Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation

The Lats2 tumor suppressor protein has previously been implicated in promoting p53 activation in response to mitotic apparatus stress, by preventing Mdm2-driven p53 degradation. We now report that Lats2 also plays a role in an ATR-Chk1-mediated stress checkpoint in response to oncogenic H-Ras. Activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Aylon, Yael, Yabuta, Norikazu, Besserglick, Hila, Buganim, Yossi, Rotter, Varda, Nojima, Hiroshi, Oren, Moshe
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795787/
https://www.ncbi.nlm.nih.gov/pubmed/19855428
http://dx.doi.org/10.1038/onc.2009.270
_version_ 1782175452080635904
author Aylon, Yael
Yabuta, Norikazu
Besserglick, Hila
Buganim, Yossi
Rotter, Varda
Nojima, Hiroshi
Oren, Moshe
author_facet Aylon, Yael
Yabuta, Norikazu
Besserglick, Hila
Buganim, Yossi
Rotter, Varda
Nojima, Hiroshi
Oren, Moshe
author_sort Aylon, Yael
collection PubMed
description The Lats2 tumor suppressor protein has previously been implicated in promoting p53 activation in response to mitotic apparatus stress, by preventing Mdm2-driven p53 degradation. We now report that Lats2 also plays a role in an ATR-Chk1-mediated stress checkpoint in response to oncogenic H-Ras. Activated mutant H-Ras triggers the translocation of Lats2 from centrosomes into the nucleus, coupled with an increase in Lats2 protein levels. This leads to induction of p53 activity, upregulation of proapoptotic genes, downregulation of antiapoptotic genes and eventually apoptotic cell death. Many of the cells that survive apoptosis undergo senescence. However, a fraction of the cells escape this checkpoint mechanism, despite maintaining high mutant H-Ras expression. These escapers display increased genome instability, as evidenced by a substantial fraction of cells with micronuclei and cells with polyploid genomes. Interestingly, such cells exhibit markedly reduced levels of Lats2, in conjunction with enhanced hypermethylation of the Lats2 gene promoter. Our findings suggest that Lats2 might play an important role in quenching H-Ras-induced transformation, while silencing of Lats2 expression might serve as a mechanism to enable tumor progression.
format Text
id pubmed-2795787
institution National Center for Biotechnology Information
language English
publishDate 2009
record_format MEDLINE/PubMed
spelling pubmed-27957872010-06-17 Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation Aylon, Yael Yabuta, Norikazu Besserglick, Hila Buganim, Yossi Rotter, Varda Nojima, Hiroshi Oren, Moshe Oncogene Article The Lats2 tumor suppressor protein has previously been implicated in promoting p53 activation in response to mitotic apparatus stress, by preventing Mdm2-driven p53 degradation. We now report that Lats2 also plays a role in an ATR-Chk1-mediated stress checkpoint in response to oncogenic H-Ras. Activated mutant H-Ras triggers the translocation of Lats2 from centrosomes into the nucleus, coupled with an increase in Lats2 protein levels. This leads to induction of p53 activity, upregulation of proapoptotic genes, downregulation of antiapoptotic genes and eventually apoptotic cell death. Many of the cells that survive apoptosis undergo senescence. However, a fraction of the cells escape this checkpoint mechanism, despite maintaining high mutant H-Ras expression. These escapers display increased genome instability, as evidenced by a substantial fraction of cells with micronuclei and cells with polyploid genomes. Interestingly, such cells exhibit markedly reduced levels of Lats2, in conjunction with enhanced hypermethylation of the Lats2 gene promoter. Our findings suggest that Lats2 might play an important role in quenching H-Ras-induced transformation, while silencing of Lats2 expression might serve as a mechanism to enable tumor progression. 2009-10-26 2009-12-17 /pmc/articles/PMC2795787/ /pubmed/19855428 http://dx.doi.org/10.1038/onc.2009.270 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Aylon, Yael
Yabuta, Norikazu
Besserglick, Hila
Buganim, Yossi
Rotter, Varda
Nojima, Hiroshi
Oren, Moshe
Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation
title Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation
title_full Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation
title_fullStr Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation
title_full_unstemmed Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation
title_short Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation
title_sort silencing of the lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant h-ras-driven cell transformation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795787/
https://www.ncbi.nlm.nih.gov/pubmed/19855428
http://dx.doi.org/10.1038/onc.2009.270
work_keys_str_mv AT aylonyael silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation
AT yabutanorikazu silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation
AT besserglickhila silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation
AT buganimyossi silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation
AT rottervarda silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation
AT nojimahiroshi silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation
AT orenmoshe silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation